Olema Pharmaceuticals, Inc. financial statements
Olema Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 162.45M | 10-K |
| Cash and equivalents | USD 48.3M | 10-Q |
| Total debt | USD 1.19M | EODHD |
Olema Pharmaceuticals, Inc. financials on 6ix · Olema Pharmaceuticals, Inc. on 6ix